#BIO CATALYST Biomea Fusion, Inc. (BMEA)
$BMEA: $2.73
Icovamenib (BMF-219) – (COVALENT-111)
Type 2 Diabetes Phase 2 data to be shared at ATTD 2025
$BMEA: $2.73
Icovamenib (BMF-219) – (COVALENT-111)
Type 2 Diabetes Phase 2 data to be shared at ATTD 2025